Guggenheim Capital’s Blueprint Medicines BPMC Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$1.87M Buy
14,624
+797
+6% +$102K 0.01% 670
2025
Q1
$1.22M Buy
13,827
+688
+5% +$60.9K 0.01% 807
2024
Q4
$1.15M Sell
13,139
-3,725
-22% -$325K 0.01% 850
2024
Q3
$1.56M Buy
16,864
+4,566
+37% +$422K 0.01% 909
2024
Q2
$1.33M Sell
12,298
-4,695
-28% -$506K 0.01% 977
2024
Q1
$1.61M Sell
16,993
-407
-2% -$38.6K 0.01% 971
2023
Q4
$1.6M Sell
17,400
-3,261
-16% -$301K 0.01% 936
2023
Q3
$1.04M Sell
20,661
-759
-4% -$38.1K 0.01% 1096
2023
Q2
$1.35M Sell
21,420
-4,457
-17% -$282K 0.01% 1023
2023
Q1
$1.16M Sell
25,877
-12,968
-33% -$583K 0.01% 1106
2022
Q4
$1.7M Buy
38,845
+5,975
+18% +$262K 0.01% 911
2022
Q3
$2.17M Sell
32,870
-6,314
-16% -$416K 0.02% 800
2022
Q2
$1.98M Buy
39,184
+622
+2% +$31.4K 0.02% 891
2022
Q1
$2.46M Sell
38,562
-1,338
-3% -$85.5K 0.01% 918
2021
Q4
$4.27M Sell
39,900
-6,398
-14% -$685K 0.02% 744
2021
Q3
$4.76M Buy
46,298
+374
+0.8% +$38.5K 0.03% 675
2021
Q2
$4.04M Buy
45,924
+9,281
+25% +$816K 0.02% 762
2021
Q1
$3.56M Buy
36,643
+5,906
+19% +$574K 0.02% 767
2020
Q4
$3.45M Buy
30,737
+20,959
+214% +$2.35M 0.02% 739
2020
Q3
$906K Buy
9,778
+69
+0.7% +$6.39K 0.01% 1247
2020
Q2
$757K Sell
9,709
-28,313
-74% -$2.21M 0.01% 1313
2020
Q1
$2.22M Sell
38,022
-4,143
-10% -$242K 0.02% 744
2019
Q4
$3.38M Buy
+42,165
New +$3.38M 0.03% 808
2018
Q4
Sell
-47,412
Closed -$3.7M 2181
2018
Q3
$3.7M Buy
47,412
+1,150
+2% +$89.8K 0.02% 891
2018
Q2
$2.94M Buy
46,262
+5,911
+15% +$375K 0.02% 1024
2018
Q1
$3.7M Buy
40,351
+4,005
+11% +$367K 0.01% 1188
2017
Q4
$2.74M Buy
+36,346
New +$2.74M 0.01% 1437